Aligos Belgium
Gaston Geenslaan 1/(Gebouw 3)
3001 Leuven
BE
Aligos Belgium
Foundation date
10/09/2018
Sector
#Biotechnology - TherapeuticsSubsector
Therapeutic areas
- #Endocrine - nutritional and metabolic diseases
- #Infectious and parasitic diseases
- #Neoplasms / cancer / oncology
ALIGOS BELGIUM is the European branch of Aligos Therapeutics. It's a biotechnology company developing novel therapeutic agents to treat significant liver diseases.
Upcoming events
All events-
1605 '24
Knowledge for Growth 2024
Event by: flanders.bio -
1505 '24
State of the Union by VIB & flanders.bio
Event by: flanders.bio & VIB -
2105 '24
IOT Solutions World Congress 2024
Event by: Fira Barcelona
Latest news
More news-
V-Bio Ventures leads €20 million Series A financing of Precision oncology company Flindr Therapeutics to advance first-in-class small molecule inhibitors
11 hours ago
Read more
-
Labconsort and NEKTARI join forces for a more sustainable and social industry
Saturday April 20th 2024
Read more
-
BIO INX Complements Advisory Board with Distinguished Industry Leaders
Thursday April 18th 2024
Read more
Jobs
More jobs-
24/04/24
Brussels
Laboratory Technician / Scientific Collaborator in Protein Biochemistry
Permanent
VIB -
23/04/24
Brussels
PhD Student Position: Fluorescent Biosensors in Neurodegenerative Diseases
Permanent
VIB -
23/04/24
Flemish Brabant
PhD Research position: multi-omics liquid biopsy platform to advance precision cancer medicine. (ref. BAP-2024-251)
Temporary
KU Leuven
More info?
Ellen Telleir
Communication Coordinator